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Abstract 
Leukodystrophies are a heterogeneous group of rare inherited disorders that involve 
preferentially the white matter of the central nervous system (CNS). These conditions are 
characterized by a primary glial cell and myelin sheath pathology of variable etiology, which 
causes secondary axonal degeneration, generally emerging with disease progression.
Whole exome sequencing performed in 5 large consanguineous nuclear families allowed to 
identify homozygosity for two recurrent missense variants affecting highly conserved 
residues of RNF220 as the causative event underlying a novel form of leukodystrophy with 
ataxia and sensorineural deafness. 
We report on two homozygous missense variants (p.R363Q and p.R365Q) in the ubiquitin E3 
ligase RNF220 as the cause underlying a novel form of leukodystrophy with ataxia and 
sensorineural deafness having fibrotic cardiomyopathy and hepatopathy as associated 
features, in seven consanguineous families. Mass spectrometry analysis identified lamin B1 
as RNF220 binding protein and co-immunoprecipitation experiments demonstrated reduced 
binding of both RNF220 mutants to lamin B1. We demonstrate that RNF220 silencing in 
Drosophila melanogaster specifically affects proper localization of lamin Dm0, the fly lamin 
B1 orthologue, promotes its aggregation, and causes a neurodegenerative phenotype, strongly 
supporting the functional link between RNF220 and lamin B1. Finally, we demonstrate that 
RNF220 plays a crucial role in the maintenance of nuclear morphology: mutations primary 
skin fibroblasts determine nuclear abnormalities such as blebs, herniations and invaginations, 
which are typically observed in cells of patients affected by laminopathies.
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Overall, our data identify RNF220 as a gene implicated in leukodystrophy with ataxia and 
sensorineural deafness, and document a critical role of RNF220 in the regulation of nuclear 
lamina. Our findings provide further evidence on the direct link between nuclear lamina 
dysfunction and neurodegeneration.
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Research Division, Bambino Gesù Children's Hospital, IRCCS, V.le S. Paolo, 15, 00146 
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Introduction 
Leukodystrophies are a group of neurodegenerative diseases resulting from inherited defects 
of the myelin sheath formation and/or maintenance, in pyramidal and cerebellar neurons1, 2. 
They represent an important cause of progressive neurological disability in young patients. 
Although many forms have recognizable genetic, imaging and metabolic patterns, there are 
still cases running in families with unsolved etiology3.
We report on a novel form of autosomal recessive leukodystrophy identified in seven nuclear 
families characterized by progressive ataxia and deafness (AR-LAD) combined with fibrotic 
cardiomyopathy and hepatopathy as major associated features. 
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Whole exome sequencing (WES) performed in 5 large consanguineous nuclear families 
allowed to identify homozygosity for two recurrent missense variants affecting highly 
conserved residues of RNF220 as the causative event underlying AR-LAD.
RNF220 encodes an evolutionally conserved RING finger E3 ubiquitin ligase4 highly 
expressed in developing nervous system where it modulates both ventral spinal cord 
patterning5-7 and cerebellum development8. According with its neuronal expression, RNF220 
has recently been involved in the regulation of neural stem cell proliferation and 
differentiation9, and in the development of noradrenergic neurons10. 
In this study, we demonstrate that RNF220 protein, which is mutated in this novel syndromic 
leukodystrophy AR-LAD, binds lamin B1 and plays a crucial role in the maintenance of 
nuclear integrity by regulating nuclear laminar proteins. Interestingly, this form of 
hypomyelinating leukodystrophy recalls, for some aspects, the adult-onset autosomal 
dominant leukodystrophy (ADLD) caused by either genomic duplications encompassing the 
lamin B1 gene (LMNB1) or deletions upstream of this gene. LMNB1 encodes one of the 
major component of the nuclear lamina and all ADLD-related mutations result in increased 
lamin B1 protein levels in brain tissue of affected individuals11, 12.
Overall, our findings provide new insights into RNF220 nuclear functions and its 
involvement in AR-LAD pathogenesis, and corroborate the implication of nuclear lamina 
defects in the pathogenesis of brain white matter disorders.
Materials and methods 
Standard protocol approvals, registrations, and patient consent
The study was approved by the Ethical Committees of the Children Hospital Bambino Gesù, 
Rome, Italy in agreement with the Declaration of Helsinki. Informed consent was signed by 
the parents of the patients.
WES and Proteomic analysis
Detailed methods of WES analysis and Proteomic analysis are described in Supplementary 
Material.
Cell Culture
COS1, HEK-293T and human primary skin fibroblasts were grown in Dulbecco’s modified 
Eagle’s medium (high glucose formulation) supplemented with 10% fetal bovine serum 
(Thermo Fisher Scientific), 2 mM L-glutamine and 1% penicillin-streptomycin antibiotics, at 
37°C in a 5% CO2 humidified atmosphere. iPSCs were purchased from Coriell Institute 
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(USA, Cod GM23338, GM23340). The iPSCs were derived from human fibroblasts and 
reprogrammed using the episomal technology. iPSCs were differentiated into motor neurons 
as previously described13.
Plasmid constructs
To generate RNF220 constructs, the entire cDNA sequence (NM-018150) was amplified 
from the cDNA clone MGC39525 (Thermo Scientific) and inserted into pFLAG-CMW-6a 
vector. RNF220 mutants were generated by site-direct mutagenesis using the QuikChange-
XLII Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer’s 
instructions.All the constructs were confirmed by DNA sequencing. 
Cell transfection
Transient transfection of COS-1 and HEK-293 cells was achieved by using Lifpofectamin 
2000 reagent, according to the manufacturer’s instructions (Thermo Fisher Scientific). Forty-
eight hours after transfection, cells were fixed or recovered for protein extraction.
Preparation of nuclear extracts and co-immunoprecipitation experiments
Preparation of nuclear extracts from transiently transfected or mock transfected HEK-293T 
cells was performed as previously described14. 400 µg of nuclear extract was incubated with 
30 l of anti-FLAG M2 antibody covalently bound to agarose beads at 4°C for 1 hour, under 
gently rock. After incubation, samples were centrifugated to pellet FLAG resins. After 
extensive washing, retained proteins were resuspended in 30 µl of Laemmli buffer, separated 
on SDS-PAGE and analyzed by western blotting.
Immunohistochemistry
CD1 mouse brain slices were fixed in 4% PFA at 4°C for 20 minutes, permeabilized in PBS-
0.15% Triton X-100 (Sigma), blocked for 1 hour in PBS-5% BSA (Sigma) and incubated 
with primary antibodies at 4°C overnight. Primary antibodies were diluted in PBS-1% BSA 
by the following dilutions: rabbit anti RNF220 (1:50, Sigma), mouse anti Smi32 (1:500, 
Sigma), mouse anti Calbindin (1:500, Sigma), mouse anti GFAP (1:500, BD Biosciences). 
Slices were washed three times in PBS and incubated with Alexa Fluor-conjugated secondary 
antibodies (Thermo Fisher Scientific) for 1 hour at room temperature and nuclei were 
counterstained with Hoechst (Sigma).
Immunocytochemistry
Fibroblasts were seeded in 24-well cluster plates onto 12 mm cover glasses. After 24 hours of 
culture in complete medium, cells were fixed with ice–cold methanol for 7 minutes, blocked 
with PBS-5% BSA (Sigma) for 1 hour and subsequently incubated with the indicated primary 
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antibodies at 4°C overnight. Primary antibodies were diluted in PBS-1% BSA by the 
following dilutions: mouse anti Lamin AC (1:50, Santa Cruz), rabbit anti Lamin B1 (1:500, 
Abcam), mouse anti Nesprin-1 (MANNES1A-7A12) (1:50, Thermo Fisher Scientific)15. 
Cells were washed three times in PBS and incubated with Alexa Fluor-conjugated secondary 
antibodies (Thermo Fisher Scientific) for 1 hour at room temperature. Nuclei were 
counterstained with Hoechst (Sigma). 
COS-1 cells transiently transfected were fixed in 4% PFA for 15 minutes, blocked with PBS-
5% BSA (Sigma) for 1 hour and subsequently incubated with the primary mouse anti FLAG 
antibody (1:500, Sigma) for 1 hour at room temperature or with the indicated primary 
antibodies at 4°C overnight: rabbit anti 20S Proteasome (1:100, Thermo Fisher Scientific) 
rabbit anti ASF/SF2 (1:100, Abcam). Cells were washed three times in PBS and incubated 
with Alexa Fluor-conjugated secondary antibodies (Thermo Fisher Scientific) for 1 hour at 
room temperature. Nuclei were Hoechst (Sigma) counterstained. 
Confocal microscopy analysis
Confocal imaging was performed on an Olympus Fluoview FV1000 confocal microscope 
equipped with Multi Ar (458–488 and 515 nm), 2X He/Ne (543 and 633 nm), and 405-nm 
diode lasers. Sequential confocal images were acquired using a HC PLAPO CS2 40× oil-
immersion objective with a 1024×1024 format, 400 Hz scan speed and a z-step size of 0.4 
µm. The lasers’ power, beam splitters, filter settings, pinhole diameter and scan mode were 
the same for all examined samples of each staining. The spatial relationship between RNF220 
and 20S proteasome was quantified by co-localization analysis module of LAS X Leica 
software, using Manders' Overlap Coefficient (OC).  Its value can range from 0 to 1, with 0 
represents a total exclusion, 0,5 a random overlap, and 1 reflecting 100% co-localization 
between both images. The co-localization is considered significant when OC>0.5.
Drosophila strains and crosses
Flies stocks were maintained on Drosophila standard medium (Nutri-fly Genesee Scientific) 
at 25°C and crosses were performed at 18 and 25°C. RNF220 down regulation in different 
tissues was obtained by crossing UAS RNF220 RNAi (BDSC 61303) with Eyless-GAL4 
(eye imaginal disc and larval salivary glands), GMR-GAL4 (adult eye) or Mef2-GAL4 
(larval muscles) flies. All stocks were provided by Bloomington Stock Center and described 
in flybase.org.
Drosophila salivary glands immunostaining 
Third instar larval salivary glands were dissected in 0.7% NaCl, transferred in 1.8% 
formaldehyde and 40% acetic acid on a coverslip, gently squashed and immediately frozen in 
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liquid nitrogen. After flipping off the coverslip, slides were immersed in ice cold TBS for 10 
minutes and permeabilized for 20 minutes in TBS-Triton 1%. Slides were then incubated 
with anti Lamin Dm0 (1:10; ADL67.10-S Developmental Studies Hybridoma Bank) and Anti 
Lamin C (1:10; LC28.26-S Developmental Studies Hybridoma Bank) antibodies overnight at 
4°C in a wet chamber. Salivary glands preparations were washed 10 minutes with TBS-
Triton 0,05% and incubated with anti-mouse TRITC (Jackson Immuno Research) 1 hour at 
room temperature. After two washes with TBS-Triton 0,05%, slides were mounted in 
VECTASHIELD Antifade Mounting Medium with DAPI (Vector) to stain DNA. Intact 
polytene chromosomes nuclei were analyzed using a Zeiss Axioplan epifluorescence 
microscope (Carl Zeiss) equipped with a cooled CCD camera (Photometrics). Images were 
pseudo coloured and merged with Adobe Photoshop CS4. 
RNA extraction, cDNA synthetis, Real-Time PCR and PCR
Total RNA from UAS-RNF220-RNAi/Mef2 GAL4 and control +/Mef2 GAL4 were 
extracted from third instar larvae (2 larvae/sample) using Nucleozol (Macherey Nagel) by 
following the manufacturer’s manual and genomic DNA was digested with InvitrogenTM 
Dnase I Amplification Grade (Thermo Fisher Scientific). 400 ng of each total RNA were 
retrotranscribed into equal amount of cDNA by using the iScript™ cDNA Synthesis Kit 
(Bio-Rad) and 35 ng of cDNA for each reaction were amplified in a quantitative Real-Time 
PCR using SsoAdvanced™ Universal SYBR® Green Supermix kit (Bio-Rad) according to 
the manufacturer’s protocol.
Total RNA from skin fibroblasts of patients and healthy individuals were isolated using the 
Total RNA Purification Plus kit (Norgen Biotek Corp), according to the manufacturer’s 
protocol. 500 ng of each RNA samples was reverse transcribed with the LunaScript RT 
SuperMix Kit (Euroclone) and 25 ng of cDNA for each reaction were amplified in a 
quantitative Real-Time PCR using Power SYBR Green PCR Master Mix (Thermo Fisher 
Scientific).
RNF220 splice variants  were amplified  using 25 ng of cDNA obtained from skin fibroblast 
of patients and healthy individuals and a commercial total human brain (Takara BIO) using 
the KAPA Taq PCR Kit (Roche).
The determination of the expression levels of the RNF220 mRNA in a commercially 
available human cDNA panels from healthy adult tissues (Takara BIO) and fetal brain areas 
(BioChain, Newark, CA) was analyzed by quantitative Real-time PCR using two inventoried 
TaqMan®-MBP probes (Thermo Fisher Scientific).
Data analysis and Statistics
Page 8 of 69









niversity of Torino user on 02 O
ctober 2021
Results are presented as the mean ± standard error of the mean (SEM). The statistical analysis 
was performed using the GRAPHPAD/Prism 7.0 Software (GraphPad Software). Statistically 
significant differences between groups were analyzed using the Student’s t-test for normally 
distributed variables. Statistical significance was defined as * p ≤ 0.05, ** p ≤ 0.005, *** p ≤ 
0.0005,**** p ≤ 0.0001.
Data availability 
LC-MS raw data (e.g. mass spectra) have not been shared because they would need specific 
software to be visualized, but are available upon request.  The data we shared (Supplementary 
Table 3) are representative of raw data processing.
Results 
Patients and genomic analyses 
We studied by WES a trio from a consanguineous nuclear family of Roma ethnicity 
originating from Croatia (family pedigree 2) (Fig. 1A). In this family, 3 sibs were affected by 
a similar early-onset hypomyelinating leukodystrophy, having progressive ataxia, 
sensorineural deafness, fibrotic cardiomyopathy and hepatopathy as major associated 
features. Cardiac manifestations progressed to dilated cardiomyopathy that caused their death 
by the end of the first decade (Table 1, Supplementary file). The proband pt I, 3 had been 
enrolled in the “Undiagnosed Patients Program”, Ospedale Pediatrico Bambino Gesù, Rome. 
WES analysis excluded the occurrence of any functionally relevant variant (s) compatible 
with known Mendelian disorders based on the expected inheritance model and clinical 
presentation. Our variant filtering and prioritization strategy lead us to identify 8 genes 
carrying putative deleterious biallelic variants as the best candidates underlying the trait 
(Supplementary Table 1). A following analysis taking advantage of gnomAD’s gene 
constraint metrics16 highlighted that RNF220 (MIM 616136) has by far the highest 
probability of being loss-of-function intolerant (pLI =1, observed-to-expected ratio 
(o/e)=0.03-0.2) in the gene. Moreover, a bioinformatic analysis showed that Arg365 is 
intolerant to missense variants (MetaDome’s tolerance score (dn/ds) = 0.51; Supplementary 
Fig. 1;17). Overall, RNF220 (NM_018150.4:c.1094G>A, p.(R365Q), with a CADD score of 
25.8 was identified as the only putative candidate fitting the recessive transmission of the trait 
and homozygosity by descent. Co-segregation analysis confirmed homozygosity for the 
missense change in the other two affected sibs as well as heterozygosity in the two obligate 
Page 9 of 69









niversity of Torino user on 02 O
ctober 2021
carriers and in 4 healthy sibs. We also annotated this variant in population genetics databases, 
with MAF<0.01 (dbSNP: rs1010750511; maximum AF in a gnomAD subpopulation = 
0.0001202, with no homozygous individuals reported).
Three nuclear related families of a large consanguineous pedigree originating from southern 
Italy were identified to transmit a superimposed phenotype characterized by ataxia, deafness, 
hypomyelinating leukodystrophy, and fatal cardiomyopathy together with hepatopathy that 
was detected in the clinical follow-up18. Homozygosity mapping including the 3 AR-LAD 
affected patients, 6 healthy sibs and four relatives (for pedigree see Leuzzi et al., 200018), 
defined a likely region of homozygosity on chromosome 1p34.3-p33 encompassing the 
RNF220 gene. Based on the clinical overlap, scan of the entire RNF220 coding sequence 
allowed to identify a second missense change affecting an adjacent residue (c.1088G>A; 
p.(R363Q)) that co-segregated as homozygous change with the trait. This mutation 
c.1088G>A, with a CADD score of 32, was heterozygous in 6 additional healthy sibs and 4 
relatives. It was annotated in the reference scientific databases with MAF<0.01 (dbSNP: 
rs780921270; maximum AF in a gnomAD subpopulation = 0.000054 and no homozygotes 
reported, dn/ds = 0.54) (Supplementary Fig.1). 
Finally, by Genematcher imputation, additional 7 affected subjects from 3 large Roma 
pedigrees (Fig. 1A) sharing an overlapping neurodegenerative disorder and homozygosity for 
the previously recognised c.1094G>A; (p.R365Q) substitution were identified. Interestingly, 
multiple sequence alignments performed with ClustalW showed that both missense variants, 
p.R363Q and p.R365Q, target evolutionary conserved residues (Fig. 1B). Genotyping for 
single nucleotide polymorphisms (SNPs) opportunely selected within the homozygous 
genomic region encompassing RNF220 from affected and apparently unrelated Roma 
subjects (Pedigree 2, 3 and 4) showed a shared haplotype indicating a founder effect 
(Supplementary Table 2).
Clinical features of patients are schematically listed in Table 1 and their clinical reports are 
summarized in the Supplemental File (Case Report). Most of the patients died during the 
follow up, and the main cause of death occurred after the appearance of a cardiomyopathy. 
Remarkably, all patients belonging to the Roma ethnicity harbouring the homozygous 
p.R365Q variant died around the end of the first decade, while patients originating from the 
southern Italian pedigree, carrying the homozygous p.R363Q, deceased by the end of the 
second decade. 
Neuroimages showed a recognizable distribution of hypomyelination that diffusely involves 
the white matter of the brain, and spares the white matter of the cerebellum (Fig. 2). Of note, 
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T2 and Flair hyperintensity was particularly enhanced at the level of the periventricular 
anterior and posterior areas.
Histological analysis of the autopsy heart sample and liver biopsy from patients showed 
significant alterations (Supplementary Fig. 2). Heart sample from autopsy of the 18 year old 
patient 3, pedigree 118 showed replacement of myofiber by fibrotic tissue associated to a 
prominent interstitial fibrosis (Supplementary Fig. 2A). Similarly, liver samples from an open 
biopsy of I,3 in pedigree 2 (Fig. 1A) showed bridging portal fibrotic septa with chronic 
inflammation and parenchymal congestion and atrophy (Supplementary Fig. 2C). 
More interestingly, histopathological analysis of the brain samples from autopsy performed 
on patient 3 in pedigree 118 showed microvacuolar changes of the neuropile (Supplementary 
Fig. 3A and B), with no effects on astrocyte proliferation, or axonal spheroids 
(Supplementary Fig. 3A and B). Moreover, Luxol fast blu staining, to label myelin in the 
white matter, showed severe hypomyelination and diffuse gliosis, when compared to a 
control (Supplementary Fig. 3E and F).
RNF220 tissue expression profile and its localization in central nervous system 
We assessed RNF220 tissue expression profile using a commercial cDNA panel from 
different human adult tissues (Supplementary Fig. 4A). In accord with the expression data 
deposited in public database (GTEX, BioGPS and SAGE), qRT-PCR analysis revealed an 
ubiquitous expression of RNF220, which is abundant in brain and spinal cord, and 
particularly in cerebellum and cerebral cortex (Supplementary Fig. 4A). We also determined 
RNF220 mRNA levels in human foetal CNS, observing a higher expression in the 
cerebellum, spinal cord and cortex (Supplementary Fig. 4B). Furthermore, we investigated 
the distribution of RNF220 protein in mouse CNS (8 day-old mouse). To this aim, we 
conducted immunofluorescence studies on hippocampus, cerebellum and telencephalon of 
mouse brain by using a polyclonal antibody against RNF220 in combination with neural and 
glial cell markers (GFAP, Nestin, Smi32 and Calbindin). A basal expression of RNF220 was 
observed in hippocampus and telencephalon, while a prominent localization was appreciated 
in the cerebellum. In the dentate gyrus of hippocampus RNF220 was poorly detected, while it 
was predominantly observed in the molecular layer of CA1, CA2 and CA3 regions (Fig. 3). 
In telencephalon and cerebellum, RNF220 staining was detected in mature neurons that 
express the neuronal marker Smi32 (Fig. 3). Conversely, no immunoreactivity of RNF220 
was detected in astro-glial cells that are immune-reactive for GFAP, or in neural progenitor 
cells, which are identified by the expression of Nestin (Fig. 3). In particular, RNF220 was 
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widely expressed in the cerebellum where it was detected in the external granular layer, in 
deep cerebellar nuclei and in Purkinje cells, these last specifically labelled by the anti-
Calbindin antibody (Fig. 3). Further, while RNF220 in hippocampus and telencephalon 
showed a predominantly cytoplasmic and perinuclear localization, it localized primarily to 
the nucleus in cerebellar neurons (Fig. 3).
To further characterize the expression pattern of RNF220 in neuronal cells we investigated 
RNF220 localization at different stages of in vitro differentiation of human iPSC into motor 
neurons. As shown in Supplementary Fig. 5, at Day 0, RNF220 staining is weak and has a 
widespread cytosolic distribution, while at Day 5, when first neurons appear, RNF220 
staining greatly increases and localizes into the nucleus, according to the subcellular 
localization reported in the Human Protein Atlas. RNF220 localization remains clearly 
nuclear from Day 10 to Day 25 of in vitro differentiation. However, at Day 30, when 
differentiation is complete and motor neurons are mature, showing clearly defined axons and 
dendrites, RNF220 is widely distributed among nucleus and neurites (Supplementary Fig. 5).
Subcellular localization of RNF220 proteins in cell lines
In order to characterize the subcellular localization of wild type and mutant RNF220 we 
subcloned RNF220 cDNA in different expression vectors. Firstly, we demonstrated that the 
subcellular distribution of RNF220 was not affected by tag positioning (Supplementary Fig. 
6A). Thus, we observed in COS-1 cells transiently transfected with pFLAG-CMV-6a vector 
encoding N-terminal FLAG-tagged RNF220 (WT and mutants), that RNF220 localizes 
primarily to the nucleus (Supplementary Fig. 6A), consistently with previous findings 
reported in HEK-293T transfected cells6. In the nucleus, RNF220 labels vesicle-like 
structures with a distribution that strongly recalls nuclear speckles, dynamic interchromatin 
clusters enriched in splicing factors, which continuously exchange factors with the 
nucleoplasm and transcriptionally active regions19. Recent reports describe that proteasomal-
mediated protein degradation in the nucleus occurs in distinct nucleoplasmic foci, which 
partially overlap with nuclear speckles20, promyelocytic leukemia bodies (PML)21 and 
clustosomes22. To assess whether RNF220 vesicle-like structures colocalize with nuclear 
speckles, cells ectopically expressing wild type RNF220 were labelled, in co-
immunofluorescence experiments, with the antibody against ASF/SF2, a splicing factor 
enriched in nuclear speckles (Supplementary Fig. 6B). As shown, RNF220 significantly co-
localizes with ASF2/SF2, suggesting that RNF220 is enriched in nuclear speckles 
(Supplementary Fig. 6B). Furthermore, we explored the relationship between RNF220 and 
the ubiquitin proteasome system (UPS) in COS1-cells, by analyzing in immunofluorescence 
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experiments, RNF220 co-localization with the 20S protein complex, the catalytic core of the 
26S proteasome. The spatial relationship between RNF220 and 20S proteasome, examined by 
co-localization analysis of their confocal images, detected a partial co-distribution degree, 
thus suggesting a moderate link between the two molecules (Supplementary Fig. 6C).
Whilst wild type RNF220 rarely forms vesicle-like structures in the cytoplasm, we observed 
that RNF220 mutant proteins (both RNF220_R363Q and RNF220_R365Q) localize not only 
in nuclear speckles, but also coalesce in the cytoplasm to form protein aggregates/inclusions 
(Fig. 4). This was confirmed by localizing RNF220 by immunofluorescence in patient’s 
primary fibroblasts, showing increased signal, with abnormal increase in the cytoplasm with 
increased immunofluorescence for 20S proteasome as well (Fig. 5). 
Proteomic identification of RNF220 interacting proteins
To gain further insight into the cellular functions of RNF220, a proteomic analysis was 
performed to identify RNF220 interactors. The total lysates obtained from HEK-293T cells, 
either non transfected (mock fraction) or expressing FLAG tagged wild type RNF220, were 
immunoprecipitated using anti-FLAG monoclonal antibody covalently linked to sepharose 
beads to isolate RNF220 and its binding partners. Proteins retained by RNF220 were 
separated by SDS-PAGE, purified, and identified by liquid chromatography-tandem mass 
spectrometry. Proteins retained by RNF220, but absent in the mock fraction, are listed in 
Supplementary Table 2 . Considering the nuclear localization of RNF220, we focused our 
attention on nuclear candidate proteins (Supplementary Fig. 7). Among the putative nuclear 
interactors, an enrichment of all members of the lamin protein family (i.e., lamin B1, lamin 
AC and lamin B2) was observed, suggesting a potential role of RNF220 in the functional 
regulation of lamin proteins.
RNAi-mediated downregulation of Drosophila RNF220 specifically affects lamin B1 fly 
orthologue and causes neurodegeneration
To address a potential role of RNF220 in lamin protein regulation, we evaluated the effect of 
RNF220 silencing on fly orthologues of lamin protein family, by downregulating RNF220 
expression in Drosophila tissues through the UAS-GAL4 system. Firstly, we verified by RT-
qPCR that the expression of a specific RNF220 RNAi construct in larval muscles under 
control of Mef2-GAL4 driver at 18°C, downregulates RNF220 expression (Fig. 5A). 
Interestingly, the same RNAi construct causes adult fly lethality when expressed in larval 
muscles at 25°C. Further, we observed that RNAi-mediated downregulation of RNF220 late 
during eye development, under GMR-GAL4 at 25°C, causes a striking neurodegeneration of 
the retina (Fig. 5B, upper panel). Moreover, repression of RNF220 early during fly eye and 
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salivary gland development at 25°C, under control of eyeless-GAL4, causes adult fly 
lethality. Moreover, the same flies grown at the lower temperature of 18°C, which reduces 
RNAi expression, show severe alterations of eye development linked to significant reduction 
of eye surface (Fig. 5B, lower panel). Finally, to assess the effects of RNF220 
downregulation on the localization of fly orthologue of lamin protein family, we prepared 
salivary gland cells from fly larvae expressing RNF220 RNAi under eyeless-GAL4, at 25°C. 
Although these conditions cause adult lethality, they are compatible with larval development. 
RNF220 repression in fly salivary gland cells significantly and specifically alters the 
subcellular localization of lamin Dm0, the fly orthologue of human lamin B1, and promotes 
its accumulation (Fig. 5C). Interestingly, no effect was observed on the subcellular 
localization and expression levels of fly orthologue of lamin A/C (lamin C), in the same 
preparation (Fig. 5D).
AR-LAD mutations affect RNF220 binding activity for lamin B1
Based on the interactome data and the specific impact of RNF220 silencing on localization 
and accumulation of the fly ortholog of lamin B1, we investigated the association of 
endogenous RNF220 and lamin B1 by subcellular fractionation and co-immunoprecipitation 
experiments. Firstly, we compared the distribution of RNF-220 and lamin B1 in subcellular 
fractions of nuclei from mouse cerebellum (Supplementary Fig. 9A), which showed high 
expression of RNF220 (Fig. 3). Interestingly, RNF220 and Lamin B1 show a very similar 
distribution with a substantial enriched in the nuclear matrix fraction, which contains a very 
low amount of total proteins (Supplementary Fig. 9A). Thus, we immunoprecipated Lamin 
B1 from solubilized proteins extracted from the nuclear matrix of cerebellar cells and we 
demonstrated a significant interaction of endogenous lamin B1 with RNF220 (Fig. 6A). 
Furthermore, to assess how the mutations affect RNF220 binding activity to lamin B1 we 
performed co-immunoprecipitation experiments on nuclear lysates from HEK-293T cells 
transfected with RNF220 constructs. .Thus, we observed that both RNF220 mutants show 
reduced binding to endogenous lamin B1 as compared to WT (Fig. 6B). Reduction was 
particularly evident if we normalize the amount of retained lamin B1 for the correspondent 
level of each immunoprecipitated RNF220 variant (Fig. 6B). Interestingly, p.R365Q 
substitution affects lamin B1 binding more seriously as compared to p.R363Q mutation (Fig. 
6B).
To get insights on the molecular mechanisms underlying the role of RNF220 on the 
regulation of lamin B1, we assessed the effects of RNF220 expression on lamin B1 stability 
and ubiquitination in nuclear extracts. Since it has been already established as lamin B1 can 
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be degraded through ubiquitin-proteasome pathways23 as well as via autophagy24, we co-
expressed RNF220 and lamin B1 with tagged ubiquitin with or without Bafilomycin, a 
lysosomal inhibitor which specifically blocks the autophagy flux (Supplementary Fig. 9B). 
Thus, although lamin B1 is ubiquitinated in the absence of RNF220, its ubiquitination 
increases in the presence of RNF220 WT, and more intriguingly, RNF220 mutants 
significantly reduce the ubiquitination of nuclear Lamin B1 (Supplementary Fig. 9B). 
Noticeable, such effect is evidenced by the treatment of Bafilomycin suggesting a role of 
RNF220 on both ubiquitination and autophagy processes (Supplementary Fig. 9B).
p.R363Q and p.R365Q mutations affect nuclear lamina morphology of fibroblasts
Considering the nuclear localization of RNF220, its binding to lamin B1, one of the major 
component of the nuclear lamina, and the effects of RNF220 downregulation in Drosophila, 
we assessed the effects of RNF220 mutations on the morphology of nuclear envelop in AR-
LAD skin fibroblasts. Firstly, we verified fibroblasts as valuable system to model AR-LAD, 
by evaluating the expression level of RNF220 in these cells. Evidence from the EST database 
suggests the presence of at least six alternatively splice variants of RNF220 mRNA, three of 
which RNF220-202/203/204 (ENST00000355387, ENST00000361799, ENST00000372247) 
that encode full length protein and the three additional splice variants RNF220-201 
(ENST00000335497), RNF220-205 (ENST00000440132) and RNF220-206 
(ENST00000453863), encoding for shorter isoforms. Specific primer pairs able to detect all 
transcripts were exploited in RT-qPCR experiments from AR-LAD and control skin 
fibroblasts (Supplementary Fig. 8A). As shown in Supplementary Fig. 8B, RT-qPCR analysis 
showed the expression of different RNF220 variants in primary fibroblast culture. 
Specifically, while variants 201, 205 and 206 were amplified in fibroblasts, the full length 
variants were not detected in these cells, according to their brain specific expression 
(Supplementary Fig. 8B). Furthermore, we assessed the expression of the different spliced 
variants in fibroblasts of healthy and AR-LAD affected individuals, and we confirmed that 
variants 201, 205 and 206 are expressed in all genetic backgrounds. Thus, although RNF220 
full length variant is not expressed, other isoforms containing the protein domains carrying 
AR-LAD mutations are expressed in fibroblasts. 
Confocal analysis of AR-LAD fibroblasts, immunostained with different nuclear envelope 
markers, shows abnormal nuclear shapes in patient cells, significantly more frequent than 
controls, with multiple invaginations and lobulations (Fig.7).
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Discussion 
Here, we describe a rare form of hypomyelinating leukodystrophy manifesting as progressive 
ataxia, mild intellectual disability, and deafness. As disease progresses, patients experience 
sensory-neural deafness, resulting in complete hearing loss by their first decade of life. 
Moreover, during the follow-up most patients show signs of hepatopathy with increased AST 
(aspartate aminotransferase) and ALT (alanine aminotransferase), which is associated with 
periportal fibrosis at liver biopsy. Most importantly, all patients during the late follow-up 
develop a fatal cardiomyopathy that leads to death by the end of the second decade. 
Following the peculiar clinical and neuroradiological characteristics, we define this new type 
of white matter disease as a novel form of leukodystrophy with autosomal recessive pattern 
of inheritance and associated with ataxia and deafness (AR-LAD). The MRI in patients 
affected by AR-LAD corresponds to a hypomyelinating leukodystrophy that diffusely 
involves the entire white matter including the subcortical U fibers and the internal capsule, 
with abnormal T2 hyperintensity that is particularly enhanced at the level of the 
periventricular areas (Fig. 3). Moreover, hypomyelination characteristically spares the 
cerebellar and the brainstem white matter (Fig. 3). The distribution of hypomyelination 
differs from the one described in ADLD related to LMNB1 duplication where T2 symmetric 
diffuse hyperintensities generally spare U-fibers as well as the periventricular white matter in 
the brain, and involve the upper and middle cerebellar peduncles25. 
WES analysis allowed us to identify RNF220 as the AR-LAD causative gene, and two 
different homozygous mutations in two highly conserved and close residues (Fig. 1B) in exon 
8, c.1088G>A (p.R363Q) and c.1094G>A (p.R365Q), were identified in AR-LAD patients.  
In the Roma families, we demonstrated a founder effect of the p.R365Q mutation, for which 
we did not find any homozygosity in the major control general population database 
(gnomAD), although genomic databases limited to Roma population are not available so far.  
The phenotype-genotype correlation shows that individuals carrying the biallelic p.R365Q 
mutation are more severely affected and die around the end of the first decade, only few years 
after the onset of cardiomyopathy, while subjects harboring the homozygous p.R363Q 
mutation survive until the end of the second decade, according to the later onset of 
cardiomyopathy. Although we have not completely elucidated the reasons for this difference, 
it is interesting to notice that the loss of binding activity of p.R365Q mutant to lamin B1 and 
its propensity to form cytoplasmic aggregations are more exacerbated that the p.R363Q 
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mutant. Intriguingly, these mutations show comparatively also different activity on lamin B1 
in the in vitro ubiquitination assay (Supplementary Fig. 9B).
RNF220 has been previously described as a RING finger protein with E3 ubiquitin ligase 
activity4 which is highly expressed in developing mouse nervous system5, 6, and is involved 
by modulating the Sonic hedgehog/GLI signalling, in ventral spinal cord patterning 5, 6 and 
cerebellum development8. E3 ubiquitin ligases are key components of the UPS, one of the 
major cellular routes to eliminate misfolded proteins26, 27, and catalyze the covalent 
attachment of one or more ubiquitin moiety to their target proteins. These modifications exert 
diverse effects, ranging from proteasome-dependent proteolysis to post translational 
modifications that modulate protein function, structural conformation and subcellular 
localization28-31. 
Consistent with previous studies5, 6, 8, we observed a widespread expression of RNF220 in 
mouse central nervous system, with a predominant localization in the cerebellum: in the 
external granular layer, deep cerebellar nuclei and Purkinje cells (Fig. 4). Moreover, 
according to its reported role in the mouse spinal cord, and cerebellum pattern formation5, 6, 8, 
we also detected high expression levels of human RNF220 mRNA in fetal and adult spinal 
cord, and cerebellum (Supplementary Fig. 4).
In order to characterize the effect of AR-LAD-linked mutations on the subcellular 
localization of RNF220 we expressed wild type and mutant RNF220 variants in COS-1 cells 
and we observed their preferential nuclear localization (Supplementary Fig. 6A). We showed 
that wild type RNF220 protein mainly localizes in the nuclear speckles as demonstrated by 
the co-localization with ASF/SF2 (Supplementary Fig. 6B). Interestingly, nuclear speckles, 
beside their well-known role of interchromatin clusters enriched in pre-mRNA splicing 
factors, are likely involved in protein degradation via UPS20. Accordingly, we observed also a 
co-localization of RNF220 positive nuclear speckles with the 20S proteasome complex 
although was not highly significant (Supplementary Fig. 6C). RNF220 carrying p.R363Q and 
p.R365Q mutations do not localize exclusively in nuclear speckles, but also coalesces into the 
cytoplasm to form protein inclusions. This observation strongly suggests that AR-LAD 
mutations affect RNF220 subcellular localization and increase its cytoplasmic aggregation 
(Fig. 5).
We used a proteomic-based approach to identify RNF220 binding partners. Mass 
spectrometry analysis detected, among RNF220 nuclear binding proteins, all components of 
lamin protein family: lamin B1, lamin AC and lamin B2 (Supplementary Fig. 7). By RNAi-
mediated downregulation of RNF220 in different fly tissues we demonstrated that RNF220 
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silencing affects the subcellular localization of lamin Dm0, the fly orthologue of lamin B1, 
promoting its aggregation and neurodegeneration (Fig. 5). Further, RNF220 silencing does 
not affect the subcellular localization of fly orthologue of lamin A/C, suggesting that RNF220 
dysregulation primarily targets lamin B1. Thus, we validated, by co-immunoprecipitation 
experiments, RNF220 and lamin B1 protein association and we demonstrated that AR-LAD 
mutations, particularly p.R365Q, significantly diminish RNF220 binding to lamin B1..  
Lamin B1, encoded by the LMNB1 gene, is a member of the intermediate filament protein 
family and is part of the nuclear lamina, the protein meshwork lining the inner surface of the 
nuclear envelope32, 33. Nuclear lamina not only provides mechanical support to the nucleus, 
but also plays a dynamic role in the organization and regulation of chromatin, transcription, 
DNA replication, DNA repair and epigenetic modifications34-40. Lamin B1 is critical for 
proper brain development41-45 and the entire CNS is susceptible to modifications of LMNB1 
levels11, 12, 46-48. Duplication of LMNB1 or a large deletion of 660kb upstream this gene, 
which dysregulate the LMNB1 gene dosage in brain tissue, have been reported to cause a 
severe progressive demyelinating disorder represented by an adult form of dominant 
leukodystrophy (ADLD)11, 12, 48-51. ADLD patients exhibit increased levels of lamin B1 
transcript and protein in specific degenerating cerebral area, indicating that abnormal levels 
of lamin B1 have deleterious consequences11, 12. Interestingly, AR-LAD hypomyelination 
reminds the deficiency in myelin deposition observed in ADLD, and suggests that the 
reduced interaction of RNF220 with lamin B1 may selectively affect oligodendrocytes, and 
neurons which are the most sensitive cells to lamin B1 dysregulation11, 52-58. Indeed, it has 
been observed that lamin B1 overexpression in oligodendrocytes leads to a premature 
differentiation arrest and suppression of myelin biosynthesis53. Accordingly, lamin B1 is 
tightly regulated during brain development, showing an expression pattern complementary to 
that of several myelin proteins55, and particularly oligodendrocyte differentiation is 
characterized by a progressive decline of lamin B1 expression58. Furthermore, lamin B1 
levels vary during neurogenesis59, 60 and differentially regulate axon and dendrite 
outgrowth58. This tight modulation of lamin B1 protein dosage implies the involvement of 
specific regulatory mechanisms. Recent studies have highlighted an important role of UPS in 
lamin B1 turnover61-63 and different E3 ligases, such as RNF123 and HECW2, have been 
reported to bind and target lamin B1 for proteasome proteolysis61, 62. Moreover, 
overexpression of human lamin B1 in Drosophila eyes causes a retina neurodegeneration11 
that strongly resembles the phenotype observed in flies expressing RNF220 RNAi construct 
(Fig. 5). According to the nuclear localization of RNF220, and its functional connection with 
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lamin B1, we investigated the impact of RNF220 mutations on nuclear lamina morphology in 
AR-LAD primary fibroblasts. Morphological analysis of nuclear envelope in AR-LAD 
fibroblasts reveals a higher frequency of blebs, herniations and honeycomb structures, which 
are typically observed in laminopathic patient cells (Fig. 7). These findings confirm the 
involvement of RNF220 in the maintenance of nuclear integrity and allow to hypothesize that 
the cardiomyopathy developed by the patients may be related to a secondary laminopathy.
Indeed the fatal dilated cardiomyopathy with diffuse fibrosis seen in AR-LAD is suggestive 
of the cardiomyopathy observed in patients affected by laminopathies64-66. Laminopathic 
patients harbor mutations in the LMNA gene, encoding A-type lamins (Lamin A-C), two 
structural components of the nuclear lamina, or in other genes encoding proteins functionally 
related to lamin A-C67.
Therefore, in the light of these pieces of evidence we cannot exclude that RNF220 mutations 
may impair its binding to additional lamins and that other laminar proteins may contribute to 
the morphological alterations observed in AR-LAD cells. Indeed, several indications link, 
directly or indirectly, laminopathies to an impairment of UPS68-70. Specific components of the 
UPS are activated by lamin miss-expression68,71,72 and clearance of the inner nuclear 
membrane proteins have been reported to be proteasome-mediated73,74. Furthermore, some 
deleterious mutations of the lamin A-C proteins specifically affect their interaction with 
ubiquitin E3 ligases62, 72, 75. It has also reported that components of nuclear lamina are 
degraded by the autophagy machinery through a direct interaction of lamin B1 with LC3, a 
major regulator of autophagy, in a specific transport from nucleus to cytoplasm which ends 
with lysosomal degradation24.
Unfortunately we had no direct access to any affected post-mitotic tissue of patients, such as 
the brain, which is the tissue mainly affected by AR-LAD leukodystrophy, to verify a 
possible accumulation of lamin proteins in degenerating cerebral areas. Although the absence 
of patient’s autoptic tissues represent a great limitation, our in vitro and in vivo experiments 
strongly support the involvement of RNF220 in lamin B1 and potentially other lamin proteins 
turnover.
Finally, mutations in genes encoding proteins of the linker of nucleoskeleton and 
cytoskeleton (LINC) complex, that associate nuclear lamina to the cytoskeleton, have been 
reported to cause hereditary hearing loss77, 78. In mice deficient in structural proteins of the 
LINC complex outer hair fail to maintain the basal localization of their nuclei and degenerate 
as hearing matures76, 77. Considering that all AR-LAD patients experienced sensory-neural 
Page 19 of 69









niversity of Torino user on 02 O
ctober 2021
deafness resulting in complete hearing loss within the first decade, it is captivating to 
hypothesize that alterations of nuclear lamina in AR-LAD cells may impair its connection 
with the cytoskeleton via the LINC complex, causing hearing loss. Accordingly, it has also 
been recently observed in Drosophila that mutations in the Parkin-like E3 ubiquitin ligase 
Ariadne-1, which regulates LINC complex, alter nuclear morphology of larval muscles, and 
that rare variants of human homolog of this gene are associated with thoracic aortic 
aneurysms due to aberrant nuclear envelop function in smooth muscle cell78.
Overall, our findings shed new lights on RNF220 nuclear functions and strongly suggest that 
RNF220 may play a key role in the maintenance of nuclear integrity by regulating laminar 
proteins. 
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Figure legends
Figure 1A and B. Fig 1A. Pedigrees of the families. Pedigree1# is reported in Leuzzi et al., 
2000. Fig.1B. Multiple sequence alignment of RNF220 proteins. Multiple sequence 
alignment of RNF220 proteins (ClustalW) from different organisms around the sites affected 
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by AR-LAD mutations R363Q and R365Q (in red). “*” indicates perfect conservation ,“:” 
indicates strong similarity, “.” indicates weak similarity.
Figure 2. MRI characteristics of AR-LAD. A-E, and I: pedigree 4, Pt II,1 at age 7; F-H: 
pedigree 3, Pt I,3 at age 7y; J-L: pedigree 1, Pt 3 at age 7y. Images demonstrate very similar 
findings: T2 weighted image are A-C, E, F-K, show diffuse T2 hyperintensity in the white 
matter of the brain suggesting a hypomyelinating leukoencephalopathy.T2 hyperintense areas 
were particularly enhanced at the level of the periventricular white matter areas (arrows). 
Note the normal myelination of cerebellar white matter in I and K, and the global corpus 
callosum thinning on T1 weighted image (D, L). 
Figure 3. RNF220 immunohistochemical detection in the CNS of a 8 day-old mice. 
Significant expression of RNF220 is observed in the molecular layer of hippocampus, in 
telencephalon, with a conspicuous signal in the cerebellum. Upper panel) Sagittal brain 
sections from 8 day-old mouse were stained for RNF220 in combination with the neural 
markers Smi32 and Calbindin, and astro-glial marker GFAP. Nuclei were counterstained with 
Hoechst (Scale bar=100µm). Inserts are magnifications of the selected areas. (Scale bar=  
25µm). Lower panel) Higher magnification of sagittal cerebellum sections from 8 day-old 
mice labelled for RNF220 in combination with the neuronal markers Smi32 and Calbindin. 
Nuclei were counterstained with Hoechst (Scale bar= 25µm).
Figure 4. RNF220 subcellular localization in COS-1 cells at different times of 
transfections and RNF220 and 20S-proteasome subcellular localizations in AR-LAD 
primary fibroblasts.  A) Left panel. COS-1 cells transfected using 1 ug of FLAG-tagged 
RNF220 (wild-type or mutants) were immunostained with the anti-FLAG antibody and 
Hoechst, after 24 hours of transfection (Scale bar= 25µm). Bar graph indicates the frequency 
of nuclear and cytosolic localization of RNF220 (wild type and mutants). Results are 
presented as mean  ± SEM (n=123 cells from WT, 141 cells from R363Q, 135 cells from 
R365Q). Student’s t-test, ** p ≤ 0.01. Right panel. COS-1 cells expressing FLAG-tagged 
RNF220 (wild-type or mutants) were immunostained with the anti-FLAG antibody and 
Hoechst, after 48 hours of transfection (Scale bar= 25µm). Results are presented as mean ± 
SEM (n=150 cells from WT, 123 cells from R363Q, 137 cells from R365Q). Student’s t-test, 
* p ≤ 0.05, ** p ≤ 0.01. B) Left panel. Primary fibroblasts obtained from healthy (Ctrl)  and 
AR-LAD patients were immunostained with the anti RNF220 antibody and Hoechsts (Scale 
bar= 25µm).AR-LAD fibroblasts showed a preferential cytosolic localization of RNF220, as 
compared to control fibroblasts. Right panel. Primary fibroblastst obtained from healthy and 
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AR-LAD patients were immunostained with the anti 20Sproteasome antibody and Hoechsts 
(Scale bar= 25µm). In control fibroblasts the 20S-proteasome presents a nuclear diffuse 
distribution. In AR-LAD fibroblasts harbouring the p.R365Q substitution the 20Sproteasome 
forms cytosolic aggregate, suggesting a flooding of the overall proteolytic capacity. In AR-
LAD cells harboring the p.R363Q mutation, nuclear aggregates of the 20S-proteasome are 
observed. 
Figure 5. Effects of RNAi-mediated downregulation of RNF220 Drosophila orthologue 
in different fly tissues. A) Expression in fly muscle of a specific RNAi construct that targets 
fly RNF220, under control MEF2-GAL4 driver, at 25°C, caused adult fly lethality. Total 
RNA extracted from fly larvae expressing UAS-RNF220-RNAi under MEF2-GAL4, or the 
driver alone, was analyzed by qRT-PCR. Relative levels of RNF220 transcript between 
genotypes are shown. SEM was calculated from n = 3 independent experiments. * = P <0.05. 
B) RNAi-mediated downregulation of RNF220 significantly affects fly eye development. 
Flies expressing RNF220 RNAi construct late during eye development, under GMR-GAL4, 
show strong retina degeneration at 25 °C (upper panels). Expression of the same RNAi 
construct early during eye development, under eyeless-GAL4, causes fly lethality at 25°C. 
Flies grown at 18 °C show severe alterations of eye morphology and a significant reduction 
of eye surface (lower panels). C) RNAi repression of RNF220 in larval salivary glands 
strongly affects the subcellular localization of Lamin Dm0 and promotes its accumulation. 
Salivary gland cells were dissect from fly larvae expressing UAS-RNF220-RNAi under 
eyeless-GAL4, or eyeless-GAL4 on its own, and were stained in immunofluorescence 
experiments with antibodies against Lamin Dm0. Different rates of accumulation of lamin 
Dm0 and the different kinds of protein aggregate are shown. D) Immunofluorescence 
labeling with antibodies against Lamin C of cells from the same genotypes were used as 
control (Scale bars = 10µm).
Figure 6 A and B. Fig. 6A. Co-immunoprecipitation of lamin B1 and RNF220 from 
cerebellum extract showing tight link between RNF220 and lamin B1. Proteins in RIPA 
buffer were immunoprecipitated with anti-Lamin B1 antibody or mouse IgG, as negative 
control. Proteins retained on the beads were separated by SDS-PAGE and analyzed by 
Western blotting with corresponding antibodies. Loaded 1:50 of extract utilized for each 
immunoprecipitation as starting material (SM), and 1:2 of bound proteins as 
immunoprecipitated material (IP). Western blotting signals of two independent experiments, 
normalized on the amount of IgG, were acquired by Fiji NIH ImgeJ software, and their 
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statistical significance was assessed using GraphPad Prism software (version 8.0) with one-
way ANOVA analysis according to Sidak’s multitple comparisons test. 
p<0,01**;p<0,001*** (Left graph). Fig. 6B. RNF220 interacts with proteins of nuclear 
lamina.  Effect of p.R363Q and p.R365Q substitution on RNF220 binding activity for Lamin 
B1. The nuclear fraction of HEK-293T cells expressing FLAG-tagged RNF220 (wild type or 
mutants) were subjected to  immunoprecipitation experiments using the anti-FLAG 
monoclonal antibody covalently attached to sepharose beads to detect the interaction between 
RNF220 and endogenous Lamin B1. Both R363Q and R365Q substitutions show reduced 
binding to lamin B1 compared to WT RNF220, when the amount of lamin B1-bound is 
normalized for the level of RNF220 pulled down. The graph reports densitometric 
quantification of Lamin B1 retained by each RNF220 protein variant. Results are presented as 
mean ± SEM. n =3, Student’s t-test,* p ≤ 0.05. 
Figure7. RNF220 mutations affect nuclear envelop integrity by altering Lamin and 
Nesprin localization in AR-LAD fibroblasts. Primary fibroblasts of healthy (Ctrl) and AR-
LAD affected (R363Q and R365Q) individuals were labelled with Lamin B1, Lamin A/C and 
Nesprin 1 antibodies and counterstained with Hoechst (Scale bar=25µm). Nuclear envelop of 
AR-LAD fibroblasts show abnormal invaginations and lobulations and increased levels of all 
markers (lamin B1 A/C and Nesprin1). Bar graph indicates the frequency of cells with 
nuclear envelope defects and irregular nuclear margins. Results are presented as the mean ± 
SEM (n=251 cells from WT, 177 from R363Q, 186 cells from R365Q). Student’s t-test, **** 
p ≤ 0.001, *** p ≤ 0.005. 
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Figure 2. MRI characteristics of AR-LAD 
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Figure 3 RNF220 immunohistochemical detection in the CNS of a 8 day-old mice 
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Figure 4 RNF220 subcellular localization in COS-1 cells at different times of transfections and RNF220 and 
20S-proteasome subcellular localizations in AR-LAD primary fibroblasts 
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Figure 5 Effects of RNAi-mediated downregulation of RNF220 Drosophila orthologue in different fly tissues 
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Figure 6 Co-immunoprecipitation of lamin B1 and RNF from cerebellum extract showing tight link between 
RNF220 and lamin B1 
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Figure 7 RNF220 mutations affect nuclear envelop integrity by altering Lamin and Nesprin localization in AR-
LAD fibroblasts 
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Table 1. Details of Clinical Features
Patient ID Pedigree 1; pt 1 (Leuzzi 
et al., 2000)
Pedigree 1; pt 2 (Leuzzi et 
al., 2000)
Pedigree 1; pt 3 (Leuzzi et al., 
2000)
Pedigree 2,  pt I,3 Pedigree 3, pt I,4 Pedigree 4, pt II,4 Pedigree 4, pt II,11 Pedigree 4, pt II, 17 Pedigree 5, pt I,6
Sex F M F M M M M M F
death (age, y) 21 18 18 10 10 10 10 11 11
Ethnicity Caucasian (Southern 
Italy)
Caucasian (Southern Italy) Caucasian (Southern Italy) Roma Roma Roma Roma Roma Roma
RNF220 mutation c. 1088G>A  
p.Arg363Gly homo
c. 1088G>A  p.Arg363Gly 
homo
c. 1088G>A  p.Arg363Gly 
homo
c.1094G>A  p.Arg365Gly 
homo
c.1094G>A  p.Arg365Gly homo c.1094G>A  
p.Arg365Gly homo




c.1094G>A  p.Arg365Gly 
homo
Birth parameters
(l, w, ofc) - Centile
at term, w 3.200 gr 
(25°/50°/50°)
at term , w 3, 850  gr 
(75%ile) 50°/75°/50°
at term, w 3,000 gr 
25°/50°/50°
at term w 3380 gr 
50°/50°/50°
premature (33 weeks) w 2,010 gr 
3°/3°/3° 
At term w 3,420 gr 
50°/50°/50°
At 39 week gestation, w 
3,200 gr  25°/25°/50°
At term 3,450 gr 
50°/50°/50°
36 weeks, w 3,120 gr 
50°/50°/50°
Growth parameters (h, w, ofc) - 
Centile
at age of 7.3 yrs: w 21 
kg (25%ile); h 121 cm 
(50%ile); ofc 50.5 
(50%ile)
at the age of 7 yr: w 27 kg 
(90%ile); h 130 (90%ile) cm; 
ofc 57 (> 98%ile)
at age of 8 yr: w 52 kg (+3,05 
SD); h137.4 cm (+1.2 SD); at 
age of 9 yr ofc  55 cm (+1,67 
SD); 
At age 5 months l: 61 cm  
(<3%); w: 6.2 kg (<3%); 
ofc: 40cm (>3%)
na na at 7.5 years: h (3%ile) ; w ( 
50%ile); ofc(25% ile)




Consanguinity + + + + + + + + -
First symptoms 
(age in y, which)
developmental delay 
(mainly walking) 
developmental delay (mainly 
walking)
developmental delay (mainly 





developmental delay (walking 
and speech), intellectual 
disability




Motor developmental delay + + + + + - - - -
Intellectual disability (IQ) -(78) -(77) +(59) + +(44) -(85) + - +(67)
Neurologic manifestations
Ataxia(age at diagnosis, y) +(3) +(3) +(1) +(2) +(2,5) +(5) +(5) +(3) +(4)
Spastic paraplegia (age) + + + + + + + + +(10)
Hyperreflexia + + + + + + + +
Dysarthria + + + + + + + + +
Peripheral neuropathy (axonal) - - + + - + + - -
Seizures/EEG abnormalities - - - - - - - + -
Wheelchair-bound at age of (y) 13 16 17 9 9 9 9 8 8
Neuroimaging (MRI)
Cerebellar atrophy - + - + + - - - -
White matter involvement 
(hypomyelination)
+ + + + + + + + +
Thin corpus callosum + + + + + + + + +
Hepatic involvement
age at onset (y) 3 4 3 3 8 7 5 5 n.a.
Elevated liver enzymes (age) +(3) +(4) +(3) +(3) +(8) +(8) +(5) +(5) n.a.
Liver biopsy - - - +(hepatic fibrosis) +(hepatic fibrosis) - - +(hepatic fibrosis) -
Ultrasonography (abnormal) + + + + + + + + -
Heart Involvement
dilated cardiomyopathy (age at 
onset, y)
+(18) +(17) +(15) +(9) +(10) +(9) +(9) +(8) +(10)
Deafness
Sensorineural hearing loss (age at 
onset)
+(7) +(9) +(9) +(9) +(6) +(8) +(5) +(7,5) +(7)
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